Study: Cutaneous Squamous Cell Cancer (CSCC)
Seeking options for early-stage cutaneous squamous cell cancer (CSCC)?
See if you may be eligible for the CLEAR study. The CLEAR clinical research study is exploring an investigational treatment as a potential non-surgical treatment for adults with early-stage CSCC. This clinical trial will use an investigational drug product, the safety and efficacy of which has not been fully evaluated by Regulatory Authorities.
What is the CLEAR study?
If you were recently diagnosed with early-stage cutaneous squamous cell cancer (CSCC), please know that you are not alone in your medical journey. CSCC is one of the most common types of skin cancer and more people have been diagnosed with it in recent years. Surgery is the usual treatment that patients have for early-stage CSCC, but it still has some limitations, and many patients experience post-surgical complications.
Currently, we are working on developing potential non-surgical treatments for early-stage CSCC. CLEAR is a research study that will determine if an investigational treatment may be effective and well-tolerated compared to surgery in adults with early-stage CSCC.
This treatment is called 'investigational' as it has not yet been approved to treat early-stage CSCC.
For more information: Please contact Karina Robinson (03) 9826 4966